Cancer Therapy Startup Alpha Tau To Go Public At $1B Valuation
Alpha Tau signed an agreement with Nasdaq-listed SPAC Healthcare Capital Corp to continue delivering on its radiation cancer treatment.
July 15, 2021
Alpha Tau Gets FDA Breakthrough Device Designation For Cancer Therapy
Founded in 2016, Alpha Tau developed a breakthrough cancer treatment called Alpha DaRT (Dіffusіng Alpha-emіtters Radіatіon Therapy).
June 13, 2021
Israeli Cancer Therapy Firm Alpha Tau Medical Raises $26M
The company developed breakthrough radiation cancer therapy and is embarking on a number of new of clinical trials.
June 04, 2020
Positive Results For Alpha Tau Medical’s Breakthrough Radiation Cancer Treatment
Israeli medtech company Alpha Tau Medical announced positive results of a clinical trial involving its breakthrough alpha radiation cancer treatment method Alpha DaRT (Dіffusіng Alpha-emіtters Radіatіon Therapy.) The first clinical trial of the novel treatment, which was published in the International Journal of Radiation Oncology, Biology, and Physics, the official journal of the American Society […]
December 05, 2019
Breakthrough Cancer Therapy Developed By Israeli MedTech Startup Heads For Clinical Trials
Alpha Tau Medical's Alpha DaRT technology delivers high-precision alpha radiation that decays inside tumor, killing cancer cells while sparing surrounding healthy tissue.
November 07, 2018
Israeli MedTech Startup Alpha Tau Medical Raises $29M For Cancer Therapy
The medical company, founded in 2016, has developed an innovative alpha radiation cancer therapy that it says can kill cancer cells.
September 05, 2018
